Global Custom Aptamer Service Market Growth (Status and Outlook) 2026-2032
The global Custom Aptamer Service market size is predicted to grow from US$ 268 million in 2025 to US$ 371 million in 2032; it is expected to grow at a CAGR of 4.9% from 2026 to 2032.
Custom Aptamer Service refers to a full-spectrum customized technical service provided by biotech CROs and specialized aptamer suppliers. Based on clients’ specific targets, performance requirements, end-use scenarios and matrix conditions, providers deliver tailor-made aptamer-related solutions. The core workflow generally includes target preparation, library design, SELEX (Systematic Evolution of Ligands by Exponential Enrichment) screening, NGS bioinformatic analysis, candidate identification, binding characterization, sequence truncation & optimization, chemical modification, custom synthesis, and functional verification.
Aptamers are single-stranded oligonucleotides (ssDNA/RNA/XNA) that fold into unique 3D structures to bind targets with high affinity and specificity, also known as “chemical antibodies”. Custom aptamer services are widely applied in biomarker research, in vitro diagnostics, targeted therapeutics, biosensor development, affinity purification and drug delivery.
Custom Aptamer Service is still an emerging and relatively fragmented niche. The biggest structural driver is increasing demand for non-antibody affinity reagents.
North America currently represents the largest market for custom aptamer development. The region benefits from:
* Large biotechnology and pharmaceutical industries
* High academic research expenditure
* Strong molecular diagnostics sector
* Extensive precision-medicine programs
* Advanced oligonucleotide therapeutics ecosystem
Europe represents another important technology center. Europe has particular strengths in:
* Diagnostic development
* Biosensors
* Academic biotechnology
* Bioprocessing
* Alternative affinity reagents
Asia-Pacific remains smaller than North America but should record above-average growth as China, Japan, South Korea and other Asian economies expand biotechnology, diagnostics and oligonucleotide R&D.
The broader aptamer market similarly shows Asia-Pacific as a high-growth region; current market research associates regional expansion with increasing biopharmaceutical R&D, genomics, precision medicine and diagnostic innovation.
China in particular has the potential to become a major custom aptamer services market because of its large CRO industry, rapidly growing innovative-drug pipeline and extensive biosensor research activity.
The custom aptamer service market has witnessed growth in recent years due to several factors. One of the key drivers is the increasing demand for highly specific and selective molecular recognition tools. Aptamers offer advantages over traditional antibodies and other affinity reagents due to their small size, high affinity, stability, and cost-effective synthesis. Custom aptamer services enable researchers and companies to obtain aptamers that can bind to specific targets of interest, facilitating various applications in diverse fields. Furthermore, the market is driven by advancements in aptamer selection and optimization techniques. Custom aptamer services utilize various approaches, such as systematic evolution of ligands by exponential enrichment (SELEX) and modified SELEX protocols, to generate aptamers with desired binding properties. These services provide expertise in aptamer selection, optimization, and characterization, allowing clients to obtain aptamers that meet their specific requirements. Additionally, the market for custom aptamer services is influenced by the growing applications of aptamers in diagnostics and therapeutics. Aptamers can be used as diagnostic tools for detecting target molecules in clinical samples, including proteins, small molecules, and cells. They also hold potential as therapeutic agents, with applications in targeted drug delivery, cancer therapy, and other therapeutic modalities. Custom aptamer services play a crucial role in developing aptamers that are tailored to specific diagnostic or therapeutic needs, enabling personalized medicine and precision healthcare. The market for custom aptamer services can be segmented based on factors such as target molecule (proteins, small molecules, cells, etc.), application (diagnostics, therapeutics, research tools, etc.), end-user (academic and research institutes, pharmaceutical companies, diagnostic laboratories, etc.), and geographical region. Different service providers may offer expertise in specific aptamer selection techniques, modifications, or applications based on the needs of their clients.
Report Scope
LPI (LP Information)' newest research report, the “Custom Aptamer Service Industry Forecast” looks at past sales and reviews total world Custom Aptamer Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Custom Aptamer Service sales for 2026 through 2032. With Custom Aptamer Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Aptamer Service industry.
This Insight Report provides a comprehensive analysis of the global Custom Aptamer Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Aptamer Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Aptamer Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Aptamer Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Aptamer Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Custom Aptamer Service market by product type, application, key players and key regions and countries.
Market Segmentation
Custom Aptamer Service refers to a full-spectrum customized technical service provided by biotech CROs and specialized aptamer suppliers. Based on clients’ specific targets, performance requirements, end-use scenarios and matrix conditions, providers deliver tailor-made aptamer-related solutions. The core workflow generally includes target preparation, library design, SELEX (Systematic Evolution of Ligands by Exponential Enrichment) screening, NGS bioinformatic analysis, candidate identification, binding characterization, sequence truncation & optimization, chemical modification, custom synthesis, and functional verification.
Aptamers are single-stranded oligonucleotides (ssDNA/RNA/XNA) that fold into unique 3D structures to bind targets with high affinity and specificity, also known as “chemical antibodies”. Custom aptamer services are widely applied in biomarker research, in vitro diagnostics, targeted therapeutics, biosensor development, affinity purification and drug delivery.
Custom Aptamer Service is still an emerging and relatively fragmented niche. The biggest structural driver is increasing demand for non-antibody affinity reagents.
North America currently represents the largest market for custom aptamer development. The region benefits from:
* Large biotechnology and pharmaceutical industries
* High academic research expenditure
* Strong molecular diagnostics sector
* Extensive precision-medicine programs
* Advanced oligonucleotide therapeutics ecosystem
Europe represents another important technology center. Europe has particular strengths in:
* Diagnostic development
* Biosensors
* Academic biotechnology
* Bioprocessing
* Alternative affinity reagents
Asia-Pacific remains smaller than North America but should record above-average growth as China, Japan, South Korea and other Asian economies expand biotechnology, diagnostics and oligonucleotide R&D.
The broader aptamer market similarly shows Asia-Pacific as a high-growth region; current market research associates regional expansion with increasing biopharmaceutical R&D, genomics, precision medicine and diagnostic innovation.
China in particular has the potential to become a major custom aptamer services market because of its large CRO industry, rapidly growing innovative-drug pipeline and extensive biosensor research activity.
The custom aptamer service market has witnessed growth in recent years due to several factors. One of the key drivers is the increasing demand for highly specific and selective molecular recognition tools. Aptamers offer advantages over traditional antibodies and other affinity reagents due to their small size, high affinity, stability, and cost-effective synthesis. Custom aptamer services enable researchers and companies to obtain aptamers that can bind to specific targets of interest, facilitating various applications in diverse fields. Furthermore, the market is driven by advancements in aptamer selection and optimization techniques. Custom aptamer services utilize various approaches, such as systematic evolution of ligands by exponential enrichment (SELEX) and modified SELEX protocols, to generate aptamers with desired binding properties. These services provide expertise in aptamer selection, optimization, and characterization, allowing clients to obtain aptamers that meet their specific requirements. Additionally, the market for custom aptamer services is influenced by the growing applications of aptamers in diagnostics and therapeutics. Aptamers can be used as diagnostic tools for detecting target molecules in clinical samples, including proteins, small molecules, and cells. They also hold potential as therapeutic agents, with applications in targeted drug delivery, cancer therapy, and other therapeutic modalities. Custom aptamer services play a crucial role in developing aptamers that are tailored to specific diagnostic or therapeutic needs, enabling personalized medicine and precision healthcare. The market for custom aptamer services can be segmented based on factors such as target molecule (proteins, small molecules, cells, etc.), application (diagnostics, therapeutics, research tools, etc.), end-user (academic and research institutes, pharmaceutical companies, diagnostic laboratories, etc.), and geographical region. Different service providers may offer expertise in specific aptamer selection techniques, modifications, or applications based on the needs of their clients.
Report Scope
LPI (LP Information)' newest research report, the “Custom Aptamer Service Industry Forecast” looks at past sales and reviews total world Custom Aptamer Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Custom Aptamer Service sales for 2026 through 2032. With Custom Aptamer Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Aptamer Service industry.
This Insight Report provides a comprehensive analysis of the global Custom Aptamer Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Custom Aptamer Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Aptamer Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Aptamer Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Aptamer Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Custom Aptamer Service market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- DNA
- RNA
Segmentation by Target Category:
- Small-molecule Target Aptamer Service
- Peptide & Protein Target Aptamer Service
- Nucleic Acid Target Aptamer Service
- Cell Target Aptamer Service
- Complex Matrix Target Aptamer Service
Segmentation by End Application Purpose:
- Research-stage Aptamer Service
- Diagnostic Aptamer Service
- Therapeutic Aptamer Service
- Sample Pretreatment & Affinity Purification Aptamer Service
Segmentation by Application:
- Biology
- Scientific Research
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Aptamer Group
- Base Pair Biotechnologies
- Aptagen
- Aptamer Sciences
- Novaptech
- NeoVentures Biotechnology
- Creative Biolabs
- Creative Biogene
- AMSBIO
- Profacgen
- BOC Sciences
- Alpha Lifetech
- Eurogentec
- KMD Bioscience
- Sangon Biotech
- LinkBIO Co., Ltd.
- Aptus Biotech
- PreceDo
- CytoGroup?Cytodiagnostics?
- AptamerLab
